期刊文献+

宫颈病变高危型HPV-DNA的检测价值——附福州市1250例分析

Significance of high risk type HPV-DNA testing in diagnosis of cervical lesions-analysis of 1 250 patients in Fuzhou
下载PDF
导出
摘要 目的 探讨高危型HPV-DNA检测在宫颈病变诊断中的分析价值.方法 对1 250例宫颈病变患者进行HPV-DNA的第2代杂交捕获和液基细胞学的检测,并对结果进行分析.结果 ①随着宫颈液基细胞学检查级别升高,高危型HPV-DNA阳性率增加,HPV感染发生率增加(χ2=155.875,P〈0.05);②高危HPV-DNA阳性组宫颈高度病变(宫颈上皮内瘤变Ⅱ及以上)发病率明显高于阴性组(χ2=126.680,P〈0.05).结论 高危型HPV-DNA检测在宫颈病变诊断中有重大意义,高危HPV-DNA阳性组宫颈(宫颈上皮内瘤变Ⅱ及以上)发病率高,宫颈高度病变(宫颈上皮内瘤变Ⅱ及以上)程度也高,高危型HPV检测、宫颈液基细胞学检查及阴道镜下病理活检可提高宫颈高度病变的检出率. Objective To investigate the significance of high risk type human papillomavimses (HPV)-DNA testing in cervical lesions diagnosis. Methods 1 250 cases with cervical lesions were detected with HPV-DNA testing by hybrid capture 2 ( HC- 11 ) and liquid-based cytology test, and the results were analyzed. Results With the increasing of liquid-based cytological examination grade, the positive rate of high risk type HPV-DNA and the incidence rate of HPV infection increased (χ2 = 155. 875, P 〈 0.05 ). The incidence of high-grade cervical lesions (CIN Ⅱ and above) in positive high risk type HPV-DNA group was significantly higher than that in negative group (χ2 = 126. 680,P 〈 0.05). Conclusion High risk type HPV-DNA testing is of great significance in diagnosis of cervical lesions. The incidence and the grade of cervical lesions (CIN Ⅱ and above) are high in patients with positive high risk type HPV-DNA. High risk type HPV-DNA testing combined with cervical liquid-based cytological examination and vaginoscopic biopsy can enhance the detection rate of high-grade cervical lesions.
作者 黄晔 林仲秋
出处 《中国妇幼健康研究》 2011年第5期689-691,共3页 Chinese Journal of Woman and Child Health Research
关键词 高危型HPV-DNA检测 宫颈高度病变 细胞学检查 阴道镜检查 high risk type HPV-DNA testing high-grade cervical lesions cytological examination vaginoscopy
  • 相关文献

参考文献5

  • 1郭科军,薛晖.液基细胞学检查结果异常的处理[J].中国实用妇科与产科杂志,2007,23(7):503-505. 被引量:29
  • 2丰有吉,沈铿.妇产科学[M].2版.北京:人民卫生出版社,2010:325.
  • 3Ordi J,Alonso I,Torné A,et al.Human papillomavims load in Hybrid Captale Ⅱ assay:Does increasing the cutoff improve the test[J] ?Gynecol Oncol,2005,99(2):313-319.
  • 4Jonathan S B.NOVAK妇科学[M].段涛,丰有吉,译.14版.北京:人民卫生出版社,2007:822-823.
  • 5Cuzick J,Clavel C,Petry K U,et al.Overview of the European and North American studies on HPV testing in primary cervical cancer screening[J].Int J Cancer,2006,119(5):1095-1101.

二级参考文献12

  • 1贺桂芳,卞美璐,刘军,刘晓艳,王莹.5296例妊娠和产后妇女宫颈细胞学筛查及随访[J].中日友好医院学报,2006,20(1):13-16. 被引量:10
  • 2邓国义,方芳,彭英,杨开选,杨沛.宫颈细胞学的临床价值[J].中国妇幼保健,2006,21(19):2700-2702. 被引量:11
  • 3彭小萍,刘继红,李玉洁,熊樱,Jeffrey Tan.宫颈细胞学诊断未能除外高度上皮内瘤样病变的不典型鳞状细胞的临床意义及处理[J].中国实用妇科与产科杂志,2006,22(10):765-767. 被引量:26
  • 4Savage EW,Chapman G.Cervical dysplasia and cancer[M]//Hacker NF,Moore JG.Essentials of obstetrics and gynecology.3rd ed.Philadelphia:Saunders,1998:645.
  • 5Wright TC Jr,Cox JT,Massad LS,et al.2001 Consensus guidelines for the management of woman with cervical cytological abnormalities[J].JAMA,2002,287 (16):2120-2127.
  • 6The ASCUS-LSIL Triage Study (ALTS) Group.A randomized trial on the management of low-grade intraepithelial lesion cytology interpretations[J].Am J Obstet Gynecol,2003,188 (6):1393-1400.
  • 7Cox JT,Schiffman M,Solomon D,et al.Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy[J].Am J Obstet Gynocol,2003,188(6):1406-1412.
  • 8Benard VB,Ehemean CR,Lawson HW,et al.Cervical screening in the National Breast and Cervical Cancer Early Detection Program[J].Obstet Gynecol,2004,103(3):564-571.
  • 9Nguyen C,Montz FJ,Bristow RE.Management of stage Ⅰ cervical cancer in pregnancy[J].Obstet Gynecol Surv,2000,55(10):633-643.
  • 10Yost NP,Santoso JT,Mcintire DD,et al.Postpartum regression rates of antepartum cervical intraepithelial neoplasia Ⅱ and Ⅲ lesions[J].Obstet Cynecol,1999,93 (3):359 -362.

共引文献310

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部